Vaccines for epidemic diseases: Readiness for clinical development and regulatory submission

Deadline: 10 November 2021

Organisations can apply for a share of up to £10M inclusive of VAT, to enhance clinical and regulatory preparedness of vaccines against diseases that have outbreak potential in a low or middle income country.

This is a Small Business Research Initiative (SBRI), Official Development Assistance (ODA) competition funded by the Department of Health and Social Care (DHSC). The aim of the competition is to develop further research in vaccine technologies, or vaccine platforms to address the 12 diseases identified by the UK Vaccine Network, or Disease X.

Proposals can address any part of the pre-clinical, non-clinical, manufacturing, or clinical pathway, within a 1 year time frame, making technology ready to be progressed further along the developmental pathway. Your proposals must meet ODA requirements for funding.

Applicants should consider:

  • Ease and speed of manufacture
  • Ease of use in low to middle income countries (LMIC) settings, for example, needle free and other modes of administration
  • Temperature stability
  • Single dose or a low number of boosts
  • Length of protection
  • Vaccine platforms that can be rapidly adapted for new or re-emerging diseases.
  • Vaccines that protect against several strains of a single pathogen, or against several pathogens.

In applying to this competition, you are entering into a competitive process. This competition closes at 11am UK time on the date of the deadline.